Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Crohn Disease

Treatments: Drug: Physician standard-of-care

Study type: Observational

Funder types: Industry

Identifiers

NCT01218360

P06484

Details and patient eligibility

About

This is an observational study to determine the prevalence of moderate to severe Crohn's disease (CD) among patients with active CD and to evaluate existing therapeutic trends in a standard clinical practice.

Enrollment: 71 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

1. Must have a diagnosis of active Crohn's Disease irrespective of severity,

2. Must be inadequately controlled with their current therapy and for whom physician

   decides to switch treatment.

3. Must be between 18 and 65 years of age, of either sex,

4. Must demonstrate willingness to participate in the study by signing the written informed consent.

Exclusion Criteria

• No specific exclusion criteria will be applied to a participant as long as the participant is eligible for the trial

Trial design

71 participants in 1 patient group

Participants

Description:

All participants enrolled

Treatment:

Drug: Physician standard-of-care